In studies of people with type 2 diabetes, side effects were the number one reason for stopping treatment, which can feel discouraging if you are just starting out
When does it typically happen
The European Medicines Agency also expresses serious concerns about adverse event reports linking Ozempic and other GLP-1 drugs to gallbladder complications
Those findings add to hope that larger trials being run by Ozempics maker, Novo Nordisk, will be successful, Carrillo told CNN
Quality evidence and better-defined outcomes are paramount to guide the selection of patients for combined therapy
At Abundant Life Healthcare, many of our patients have found success with Ozempic due to its significant weight-loss benefits, often surpassing outcomes seen with other GLP-1 receptor agonists like liraglutide (Saxenda), dulaglutide (Trulicity), or exenatide (Byetta, Bydureon)